CAS 745020-66-0

NVX-207

CAS: 745020-66-0

NVX-207 is a nanoparticle-based vaccine platform, which is engineered using recombinant nanoparticle technology with a protein subunit approach. This vaccine is derived from a proprietary recombinant baculovirus that infects insect cells, enabling the production of dense, protein-filled nanoparticles. This unique mode of action allows for the stable presentation of antigens in a manner that mimics their native conformation, effectively enhancing the host's immune response.

Fórmula: C₃₆H₅₉NO₆

Pureza: Min. 95%

Peso molecular: 601.9 g/mol

Ref: 3D-VEB02066

NVX-207

CAS: 745020-66-0

NVX-207 is a derivative of betulinic acid. It has anti-cancer activity.

Fórmula: C₃₆H₅₉NO₆

Pureza: 98%

Forma y color: Solid

Peso molecular: 601.86

Ref: TM-T16368